Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.14356/1127
Title: Case of Late Recurrence in Early Stage Epithelial Ovarian Cancer
Authors: Singh, Meeta
Bista, Kesang Diki
Ojha, Neebha
Citation: SinghM., BistaK. D., & OjhaN. (2021). Case of Late Recurrence in Early Stage Epithelial Ovarian Cancer. Journal of Nepal Health Research Council, 19(2), 421-424. https://doi.org/10.33314/jnhrc.v19i2.2911
Issue Date: 2021
Publisher: Nepal Health Research Council
Article Type: Case Report
Keywords: Chemotherapy
epithelial ovarian cancer
late recurrence
secondary cytoreduction
Series/Report no.: Apr-June, 2021;2911
Abstract: Abstract Epithelial ovarian canceris usually diagnosed in late stage with high recurrence rate and fatality. Long term survival in late recurrence is not very common. We present a case of 66 year woman who had come in early stage of epithelial ovarian cancer. She survived despite having recurrence after 13 years following staging laparotomy with TAH with BSO with infracolic omentectomy and six cycles of adjuvant chemotherapy in 2007. She underwent secondary cytoreduction twice, first in 2013 and second in 2020 after she developed large pelvic mass. First secondary cytoreduction histopathology was inclusion cyst and second time it serous adencarcinoma grade III consistent with the histopathology of 2007. Both times she received chemotherapy after secondary cytoreduction including neoadjuvant chemotherapy (NACT) in 2020. She is doing well on follow up and is on oral etoposide. Keywords: Chemotherapy; epithelial ovarian cancer; late recurrence; secondary cytoreduction
Description: Case Report
URI: http://103.69.126.140:8080/handle/20.500.14356/1127
ISSN: Print ISSN: 1727-5482; Online ISSN: 1999-6217
Appears in Collections:Vol. 19 No. 2 (2021): Vol 19 No 2 Issue 51 Apr-Jun 2021

Files in This Item:
File Description SizeFormat 
2911-Manuscript-23795-1-10-20210908.pdfFulltext Download515.86 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.